Applied Molecular Transport Inc is a biotechnology business based in the US. Applied Molecular Transport Inc shares (AMTI) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Molecular Transport Inc employs 13 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $0.13 - $0.41 |
| 50-day moving average | $0.19 |
| 200-day moving average | $0.25 |
| Wall St. target price | $1.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.89 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0 from 2024-01-08
| 1 week (2024-07-16) | nan% |
|---|---|
| 1 month (2024-06-23) | nan% |
| 3 months (2024-04-23) | nan% |
| 6 months (2024-01-23) | nan% |
| 1 year (2023-07-27) | -100.00% |
|---|---|
| 2 years (2022-07-27) | -100.00% |
| 3 years (2021-07-27) | 32.03 |
| 5 years (2019-07-23) | N/A |
| Gross profit TTM | $-42,075,000 |
|---|---|
| Return on assets TTM | -51.25% |
| Return on equity TTM | -158.05% |
| Profit margin | 0% |
| Book value | $0.40 |
| Market Capitalization | $11 million |
TTM: trailing 12 months
We're not expecting Applied Molecular Transport Inc to pay a dividend over the next 12 months.
Over the last 12 months, Applied Molecular Transport Inc's shares have ranged in value from as little as $0.134 up to $0.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Molecular Transport Inc's is 2.286. This would suggest that Applied Molecular Transport Inc's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Applied Molecular Transport Inc. , a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Learn how to invest in Cathie Wood’s ARK Venture Fund in 5 easy steps.
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.